Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
UZEDY: Information from Industry
View All
Original Research
PCC
Original Research
Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders
April 1, 2002
Prakash S. Masand
,
Ahmad Hameed
,
Thomas L. Schwartz
, et al
PCC
Original Research
Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management
April 1, 2002
Mark H. Pollack
,
Jeff C. Huffman
,
Theodore A. Stern
JCP
Original Research
An Open-Label Study of Naltrexone in the Treatment of Kleptomania
April 1, 2002
Suck Won Kim
,
Jon E. Grant
JCP
Original Research
Carbamazepine Augmentation for Schizophrenia: How Good Is the Evidence?
March 1, 2002
Werner Kissling
,
Stefan Leucht
,
John McGrath
, et al
JCP
Original Research
Combining Bupropion SR With Venlafaxine, Paroxetine, or Fluoxetine: A Preliminary Report on Pharmacokinetic, Therapeutic, and Sexual Dysfunction Effects
March 1, 2002
Sidney H. Kennedy
,
Roger S. McIntyre
,
Mario Masellis
, et al
JCP
Original Research
Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder
March 1, 2002
Mark A. Frye
,
Susan L. McElroy
,
Kirk D. Denicoff
, et al
JCP
Original Research
Duloxetine in the Treatment of Major Depressive Disorder: A Double-Blind Clinical Trial
March 1, 2002
David J. Goldstein
,
Yili Lu
,
Mark A. Demitrack
, et al
JCP
Original Research
Fluoxetine Versus Placebo in Posttraumatic Stress Disorder
March 1, 2002
Ferenc Martenyi
,
Eileen B. Brown
,
Harry Zhang
, et al
JCP
Original Research
Major Depressive Disorder and Axis I Diagnostic Comorbidity
March 1, 2002
Mark Zimmerman
,
Iwona Chelminski
,
Wilson McDermut
JCP
Original Research
Normal P50 Gating in Children With Autism.
March 1, 2002
Herman van Engeland
,
Chantal Kemner
,
Bob Oranje
, et al
JCP
Original Research
An Open-Label Trial of Citalopram for Major Depression in Patients With Hepatitis C
March 1, 2002
Ondria C. Gleason
,
William R. Yates
,
M. Daniel Isbell
, et al
JCP
Original Research
Switching Patients From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine in the Maintenance of Response for Depression
March 1, 2002
Eileen B. Brown
,
Cherri M. Miner
,
Jill S. Gonzales
, et al
JCP
Original Research
Treatment of Borderline Personality Disorder With Risperidone
March 1, 2002
Paola Rocca
,
Livio Marchiaro
,
Filippo Bogetto
, et al
JCP
Original Research
Behavior Therapy for Obsessive-Compulsive Disorder Guided by a Computer or by a Clinician Compared With Relaxation as a Control
February 1, 2002
Cathryn M. Clary
,
Kenneth A. Kobak
,
Lee Baer
, et al
JCP
Original Research
Comparison Between the Effects of Atypical and Traditional Antipsychotics on Work Status for Clients in a Psychiatric Rehabilitation Program.
February 1, 2002
Sandra L. Tunis
,
Piper S. Meyer
,
Gary R. Bond
, et al
JCP
Original Research
Current Comorbidity of Psychiatric Disorders Among DSM-IV Major Depressive Disorder Patients in Psychiatric Care in the Vantaa Depression Study
February 1, 2002
Erkki T. Isometsä
,
Tarja K. Melartin
,
Heikki J. Rytsälä
, et al
JCP
Original Research
Demographic and Clinical Characteristics of Individuals in a Bipolar Disorder Case Registry.
February 1, 2002
Patricia R. Houck
,
David J. Kupfer
,
Ellen Frank
, et al
JCP
Original Research
SSRIs: Duration and Healthcare Costs
February 1, 2002
Read the full study comparing the duration and costs among 3 SSRI therapies (Fluoxetine, Paroxetine, and Sertraline).
Mark S. Bauer
,
Daniel Polsky
,
Peter Onesirosan
, et al
JCP
Original Research
Hepatotoxicity Associated With the New Antidepressants
February 1, 2002
Alfonso Carvajal García-Pando
,
Javier García del Pozo
,
Ana Sánchez Sánchez
, et al
JCP
Original Research
Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone: A Prospective Study of 113 Patients With Recent-Onset Schizophrenia or Related Disorders
February 1, 2002
Lieuwe de Haan
,
Nico Beuk
,
Britt Hoogenboom
, et al
JCP
Original Research
Predictors of Response to Pharmacotherapy in Social Anxiety Disorder: An Analysis of 3 Placebo-Controlled Paroxetine Trials
February 1, 2002
Dan J. Stein
,
Murray B. Stein
,
Cornelius D. Pitts
, et al
JCP
Original Research
What Role Do Atypical Antipsychotic Drugs Have in Treatment-Resistant Depression?
February 1, 2002
Michael E. Thase
JCP
Original Research
Stabilization of Mood From Below Versus Above Baseline in Bipolar Disorder: A New Nomenclature
February 1, 2002
Joseph R. Calabrese
,
Terrence A. Ketter
JCP
Original Research
No Weight Gain Among Elderly Schizophrenia Patients After 1 Year of Risperidone Treatment
February 1, 2002
Yoram Barak
«
1
…
138
139
140
141
142
…
164
»
